Healthcare Triangle is trading 6.24% down at $0.80 after opening-session weakness on September 4, 2026, with no reliable source identifying a new company-specific catalyst.
- A September 3 announcement described a planned Teyame AI separation, direct listing, and minority-interest stock dividend, subject to SEC review and Nasdaq approval.
- Software-sector strength does not explain the decline, while broader indices are mixed.